Tumors Metastatic to Brain Terminated Phase 3 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0029875 (Tumors Metastatic to Brain)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00096265Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung CancerTreatment